Outlook 2002: Jobs Abundant Despite Recession

Two months after the September 11 terrorist attacks the US government finally acknowledged that an already anemic economy had slipped into recession. It wasn't exactly a stop-the-presses moment. Everyone, from the guy with a few nickels in a 401k plan to big money investors, knew that Wall Street's run had ended. While every sector of the economy has suffered, the slowdown has refocused attention on the life sciences, which venture capitalists had shunned only a few years ago. In biotechnology

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

While every sector of the economy has suffered, the slowdown has refocused attention on the life sciences, which venture capitalists had shunned only a few years ago. In biotechnology and biopharmaceuticals, venture capital investments are relatively safe with a strong potential for handsome returns. And more money means more jobs for scientists and researchers. "It's a sellers market," says Tom Abt, candidate resource manager for Bench International in Beverly Hills, California. "There is a lot going on in biotech. It's in the news everyday and any time the industry is talked about it creates a lot of action. I don't see it slowing down."

Courtesy of Richard Carter

Richard Carter

The job outlook for post-doctorate jobseekers may be a little less favorable, according to industry headhunters. That said, people with the right credentials, from the right academic laboratories, working in the right field--such as oncology or genomics--should have no problem ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Bob Calandra

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio